Free Trial
→ Market down? Do this now. (From Colonial Metals) (Ad) Free FDMT Stock Alerts

4D Molecular Therapeutics (FDMT) SEC Filings & 10K Form

4D Molecular Therapeutics logo
$4.64 -0.03 (-0.64%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$4.81 +0.17 (+3.66%)
As of 02/21/2025 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent 4D Molecular Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
5:30 PM		4D Molecular Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
5:09 PM		4D Molecular Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
10:34 AM		4D Molecular Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:40 AM		4D Molecular Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SCHEDULE 13G/A
02/10/2025
4:28 PM		4D Molecular Therapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
7:37 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:36 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
3:15 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:05 PM		4D Molecular Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:46 PM		4D Molecular Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
2:15 PM		4D Molecular Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
11/14/2024
8:13 AM		4D Molecular Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
11/13/2024
3:33 PM		4D Molecular Therapeutics (Issuer)
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:17 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:08 PM		4D Molecular Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
11/12/2024
11:12 AM		4D Molecular Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
1:17 PM		4D Molecular Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
11/06/2024
5:07 PM		4D Molecular Therapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SC 13G
11/04/2024
9:55 AM		4D Molecular Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/21/2024
3:11 PM		4D Molecular Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
09/18/2024
4:46 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:06 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2024
5:04 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
7:22 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
5:04 AM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
5:13 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
4:46 PM		4D Molecular Therapeutics (Issuer)
Kirn David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
4:17 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
4:11 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:43 PM		4D Molecular Therapeutics (Subject)
Bizily Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
4:07 PM		4D Molecular Therapeutics (Issuer)
Kirn David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:44 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144/A
06/24/2024
4:39 PM		4D Molecular Therapeutics (Subject)
Kirn David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
4:04 PM		4D Molecular Therapeutics (Filer)
Form 424B5
06/07/2024
4:07 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
7:45 PM		4D Molecular Therapeutics (Issuer)
Tomasello Shawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:10 PM		4D Molecular Therapeutics (Issuer)
GRAY SUSANNAH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:11 PM		4D Molecular Therapeutics (Issuer)
MILLIGAN JOHN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:12 PM		4D Molecular Therapeutics (Issuer)
Miller-Rich Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:16 PM		4D Molecular Therapeutics (Issuer)
THEUER CHARLES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
6:17 PM		4D Molecular Therapeutics (Issuer)
Chacko Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)

Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.

>> You can grab your FREE, laminated copies right here << 
05/20/2024
7:35 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:22 PM		4D Molecular Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:09 PM		4D Molecular Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/18/2024
7:48 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:05 PM		4D Molecular Therapeutics (Filer)
Form DEF 14A
04/10/2024
3:06 PM		4D Molecular Therapeutics (Filer)
Form DEFA14A
04/10/2024
3:07 PM		4D Molecular Therapeutics (Filer)
Form ARS
04/03/2024
6:18 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:52 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
3:40 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:01 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:15 PM		4D Molecular Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/21/2024
4:41 PM		4D Molecular Therapeutics (Issuer)
Bizily Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:FDMT) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
What is this southern state hiding?
The financial press had a field day this week after President Donald Trump and Department of Government Effici...
Stansberry Research | Sponsored
Why Buffett and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this win...
Behind the Markets | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Market down? Do this now.
During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...
Colonial Metals | Sponsored
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored